scholarly article | Q13442814 |
P50 | author | Elías Campo | Q5830202 |
Marcos González Díaz | Q5996580 | ||
Itziar Salaverria | Q38319024 | ||
Julio Delgado | Q40386451 | ||
Sílvia Beà | Q42886871 | ||
Dolors Colomer | Q43096016 | ||
Alba Navarro | Q48356856 | ||
Martin Dyer | Q53138021 | ||
Cristina López | Q53260106 | ||
Guillem Clot | Q55445114 | ||
David Martín Garcia | Q57306252 | ||
Ana Carrió | Q57572856 | ||
Ana M Queirós | Q57630685 | ||
Marta Aymerich | Q60651570 | ||
Idoia Martin-Guerrero | Q83569246 | ||
Sandrine Jayne | Q85885696 | ||
Armando López-Guillermo | Q88697793 | ||
Neus Villamor | Q89017470 | ||
Lluis Armengol | Q94513572 | ||
Tycho Baumann | Q99586991 | ||
Magda Pinyol | Q117240573 | ||
P2093 | author name string | Manel García-Aragonés | |
Reiner Siebert | |||
Dolors Costa | |||
P2860 | cites work | Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations | Q24598248 |
International network of cancer genome projects | Q24611474 | ||
Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays | Q24614789 | ||
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines | Q24616084 | ||
Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia | Q24642439 | ||
Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia | Q24657747 | ||
The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia | Q27024411 | ||
Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up | Q27851444 | ||
Genomic aberrations and survival in chronic lymphocytic leukemia | Q28141442 | ||
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia | Q28255147 | ||
A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia | Q28943318 | ||
The patterns and dynamics of genomic instability in metastatic pancreatic cancer | Q29618121 | ||
Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data | Q30685440 | ||
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial | Q33291990 | ||
Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia | Q33310158 | ||
Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial | Q33419580 | ||
Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia | Q33595764 | ||
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial | Q34141305 | ||
Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease | Q34231288 | ||
Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations | Q34248736 | ||
Progressive but previously untreated CLL patients with greater array CGH complexity exhibit a less durable response to chemoimmunotherapy | Q34519192 | ||
Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. | Q34575412 | ||
Evaluation of chronic lymphocytic leukemia by BAC-based microarray analysis. | Q34608117 | ||
Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia | Q35143490 | ||
Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia | Q35220403 | ||
NOTCH1 mutations in CLL associated with trisomy 12. | Q35669190 | ||
Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia | Q36421804 | ||
CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma | Q36628297 | ||
Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia | Q37037294 | ||
From pathogenesis to treatment of chronic lymphocytic leukaemia | Q37643423 | ||
Importance of genetics in chronic lymphocytic leukemia | Q37857481 | ||
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia | Q37980658 | ||
Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand? | Q38088354 | ||
Evaluation of chronic lymphocytic leukemia by oligonucleotide-based microarray analysis uncovers novel aberrations not detected by FISH or cytogenetic analysis | Q39686496 | ||
Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse. | Q41875368 | ||
Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption | Q42537560 | ||
Sporadic and reversible chromothripsis in chronic lymphocytic leukemia revealed by longitudinal genomic analysis. | Q42789949 | ||
Improved detection rate of cytogenetic abnormalities in chronic lymphocytic leukemia and other mature B-cell neoplasms with use of CpG-oligonucleotide DSP30 and interleukin 2 stimulation | Q43493099 | ||
Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISH. | Q44052389 | ||
The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype | Q44461256 | ||
Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies | Q44664483 | ||
Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia. | Q44882002 | ||
Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial. | Q45915574 | ||
Clonal evolution in chronic lymphocytic leukemia: analysis of correlations with IGHV mutational status, NOTCH1 mutations and clinical significance | Q47916143 | ||
Comparison of array comparative genomic hybridization (aCGH) to FISH and cytogenetics in prognostic evaluation of chronic lymphocytic leukemia. | Q51529353 | ||
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia. | Q51548976 | ||
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia. | Q52621343 | ||
Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial. | Q53137883 | ||
NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome. | Q53259951 | ||
Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL. | Q53666581 | ||
High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations | Q57272648 | ||
Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia | Q57537886 | ||
Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion | Q58001017 | ||
Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages | Q58041722 | ||
p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias | Q72626720 | ||
11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis | Q73260738 | ||
A novel fusion of the MALT1 gene and the microtubule-associated protein 4 (MAP4) gene occurs in diffuse large B-cell lymphoma | Q79805104 | ||
Atypical 11q deletions identified by array CGH may be missed by FISH panels for prognostic markers in chronic lymphocytic leukemia | Q83214944 | ||
Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients | Q84537035 | ||
P433 | issue | 11 | |
P921 | main subject | lymphocyte | Q715347 |
P304 | page(s) | 668-680 | |
P577 | publication date | 2015-08-25 | |
P1433 | published in | Genes, Chromosomes and Cancer | Q5532697 |
P1476 | title | Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia | |
P478 | volume | 54 |